Background  

Over the past ten years Myelotec has invested more than $12 million to develop, patent and commercialize its steerable catheter and endoscope technology. Historically, the catheter’s primary function has been to allow physicians to diagnose and deliver a drug onto an inflamed nerve root and lyse adhesions in the epidural space.

Located in metropolitan Atlanta, Georgia, and privately held, Myelotec has made thousands of patients all over the world more comfortable, more productive—and happier—as a result of Myelotec back pain relief technology.

 

  • Founded in December, 2004
  • Products are protected under one or more of the following U.S. patents: 5,526,820; 6,146,355; 6,213,974; 6,572,536; 6,030,360; 5,868,665; 6,599,265; D454,951; D466,209; 6,855,137; 6,695,772. Other U.S. patents pending.
  • More than 100,000 procedures performed
  • Distributors worldwide